Researchers improved memory and reduced neuroinflammation in a mouse model of Alzheimer’s Disease, suggesting another avenue for potential treatment.

Four with Medical School ties are among 12 University of Michigan faculty and staff members recognized by the American Association for the Advancement of Science (AAAS) as 2023 fellows in recognition of their extraordinary achievements.

A new urine-based test addresses a major problem in prostate cancer: how to separate the slow growing form of the disease unlikely to cause harm from more aggressive cancer that needs immediate treatment.

Researchers recently revealed a new mechanism behind antiphospholipid syndrome that the investigators hope will eventually allow treatments to be targeted closer to the source of the problem.

New study has identified an enzyme contributing to systemic sclerosis.

When it comes to lupus care, Black adults are normally left behind despite being one of the highest lupus populations.

Research published in the Arthritis Care and Research Journal from Michigan Medicine found that scleroderma patients made significant strides when working with trained peer health coaches in adhering to wellness routines, leading to resilience and improvements in fatigue, pain and depressive symptoms.

Distinguished U-M neuroscientist Huda Akil, Ph.D., has received the nation’s highest scientific honor – the National Medal of Science -- for her contributions to science and their impact on humankind’s understanding of depression, anxiety, addiction and more.

Michigan Medicine researchers are examining whether ginger supplements could help treat symptoms in autoimmune diseases

Metabolism pathways make tumors sensitive or resistant to treatments. A collaborative group leverages these avenues to explore the growing foundation of new potential therapies

A neuroscientist who began his career at the University of Michigan and made important inroads in understanding the mysteries of sleep has returned to Ann Arbor to lead a fast-growing community of scientists studying the brain, nervous system and mind.

Michigan Medicine researchers looked into a drug in development to treat prostate cancer called proxalutamide, which works by blocking an enzyme called TMPRSS2 (transmembrane protease, serine 2) that is regulated by androgen receptors, as a potential therapeutic for COVID.

A study from clinicians and researchers at the University of Michigan Rogel Cancer Center reveals findings from over 800 clinical assays performed for kidney patients with MiTF family gene mutations.

There are 13 U-M graduate medical education programs ranked in the top 10 by Doximity.

An interview with Dr. Steven Kunkel on research at U-M Medical School.